Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2022
Brickell Biotech acquires exclusive rights to Carna Biosciences’ autoimmune drug portfolio
Brickell Biotech announced that it acquired exclusive rights to develop and commercialize a portfolio of autoimmune drugs created by Carna Biosciences.
2021
Brickell and Kaken partner on Phase 1 gel study in Japan
Brickell Biotech and Kaken Pharmaceutical are partnering to launch the first phase of a study of pironium bromide gel in patients with primary palmoplantar hyperhidrosis in Japan.